chr1-158638145-T-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003126.4(SPTA1):​c.5077A>C​(p.Lys1693Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.265 in 1,613,752 control chromosomes in the GnomAD database, including 59,409 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.24 ( 4874 hom., cov: 32)
Exomes 𝑓: 0.27 ( 54535 hom. )

Consequence

SPTA1
NM_003126.4 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.0140

Publications

47 publications found
Variant links:
Genes affected
SPTA1 (HGNC:11272): (spectrin alpha, erythrocytic 1) This gene encodes a member of a family of molecular scaffold proteins that link the plasma membrane to the actin cytoskeleton and functions in the determination of cell shape, arrangement of transmembrane proteins, and organization of organelles. The encoded protein is primarily composed of 22 spectrin repeats which are involved in dimer formation. It forms a component of the erythrocyte plasma membrane. Mutations in this gene result in a variety of hereditary red blood cell disorders, including elliptocytosis-2, pyropoikilocytosis, and spherocytosis, type 3. [provided by RefSeq, Aug 2017]
SPTA1 Gene-Disease associations (from GenCC):
  • hereditary spherocytosis type 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • elliptocytosis 2
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine
  • pyropoikilocytosis, hereditary
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hereditary elliptocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary spherocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=4.7916174E-4).
BP6
Variant 1-158638145-T-G is Benign according to our data. Variant chr1-158638145-T-G is described in ClinVar as Benign. ClinVar VariationId is 258943.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.437 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPTA1NM_003126.4 linkc.5077A>C p.Lys1693Gln missense_variant Exon 36 of 52 ENST00000643759.2 NP_003117.2 P02549-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPTA1ENST00000643759.2 linkc.5077A>C p.Lys1693Gln missense_variant Exon 36 of 52 NM_003126.4 ENSP00000495214.1 P02549-1

Frequencies

GnomAD3 genomes
AF:
0.239
AC:
36294
AN:
152018
Hom.:
4864
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.121
Gnomad AMI
AF:
0.325
Gnomad AMR
AF:
0.316
Gnomad ASJ
AF:
0.236
Gnomad EAS
AF:
0.452
Gnomad SAS
AF:
0.185
Gnomad FIN
AF:
0.329
Gnomad MID
AF:
0.285
Gnomad NFE
AF:
0.265
Gnomad OTH
AF:
0.259
GnomAD2 exomes
AF:
0.280
AC:
69723
AN:
249014
AF XY:
0.275
show subpopulations
Gnomad AFR exome
AF:
0.119
Gnomad AMR exome
AF:
0.363
Gnomad ASJ exome
AF:
0.237
Gnomad EAS exome
AF:
0.434
Gnomad FIN exome
AF:
0.344
Gnomad NFE exome
AF:
0.271
Gnomad OTH exome
AF:
0.285
GnomAD4 exome
AF:
0.268
AC:
391943
AN:
1461616
Hom.:
54535
Cov.:
42
AF XY:
0.265
AC XY:
192648
AN XY:
727114
show subpopulations
African (AFR)
AF:
0.119
AC:
3978
AN:
33472
American (AMR)
AF:
0.359
AC:
16023
AN:
44670
Ashkenazi Jewish (ASJ)
AF:
0.235
AC:
6135
AN:
26130
East Asian (EAS)
AF:
0.408
AC:
16198
AN:
39692
South Asian (SAS)
AF:
0.182
AC:
15705
AN:
86258
European-Finnish (FIN)
AF:
0.340
AC:
18161
AN:
53350
Middle Eastern (MID)
AF:
0.280
AC:
1615
AN:
5766
European-Non Finnish (NFE)
AF:
0.268
AC:
297441
AN:
1111894
Other (OTH)
AF:
0.276
AC:
16687
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
18516
37032
55547
74063
92579
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9938
19876
29814
39752
49690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.239
AC:
36344
AN:
152136
Hom.:
4874
Cov.:
32
AF XY:
0.243
AC XY:
18101
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.121
AC:
5038
AN:
41522
American (AMR)
AF:
0.316
AC:
4833
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.236
AC:
819
AN:
3472
East Asian (EAS)
AF:
0.452
AC:
2329
AN:
5154
South Asian (SAS)
AF:
0.186
AC:
896
AN:
4820
European-Finnish (FIN)
AF:
0.329
AC:
3488
AN:
10588
Middle Eastern (MID)
AF:
0.279
AC:
82
AN:
294
European-Non Finnish (NFE)
AF:
0.265
AC:
18012
AN:
67986
Other (OTH)
AF:
0.261
AC:
551
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1375
2750
4124
5499
6874
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
382
764
1146
1528
1910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.259
Hom.:
19196
Bravo
AF:
0.238
TwinsUK
AF:
0.268
AC:
995
ALSPAC
AF:
0.260
AC:
1002
ESP6500AA
AF:
0.123
AC:
467
ESP6500EA
AF:
0.262
AC:
2159
ExAC
AF:
0.273
AC:
33025
Asia WGS
AF:
0.347
AC:
1202
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Nov 29, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Elliptocytosis 2 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Hereditary spherocytosis type 3 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Pyropoikilocytosis, hereditary Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.81
T
BayesDel_noAF
Benign
-0.80
CADD
Benign
0.034
DANN
Benign
0.50
DEOGEN2
Benign
0.17
T;T
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.10
N
LIST_S2
Benign
0.45
.;T
MetaRNN
Benign
0.00048
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.34
N;N
PhyloP100
-0.014
PrimateAI
Benign
0.26
T
PROVEAN
Benign
0.74
N;.
REVEL
Benign
0.013
Sift
Benign
0.26
T;.
Sift4G
Uncertain
0.048
D;.
Polyphen
0.0
B;B
Vest4
0.053
MPC
0.029
ClinPred
0.0070
T
GERP RS
-5.4
Varity_R
0.28
gMVP
0.061
Mutation Taster
=94/6
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs857725; hg19: chr1-158607935; COSMIC: COSV63750569; COSMIC: COSV63750569; API